Interestingly, BIN1 was significantly associated with decreased Age of Onset (AOO) for the sporadic form of AD (p = 1.21 × 10−19) [52], suggesting its potential utility in diagnostic testing and as a target for development of therapeutics. This evidence concerns the gene BIN1 and Alzheimer disease.